GlassScriptPhysician profile
Melanie Cogan
NPI 1366631384
$1,114.03
in general payments reported to CMS, 2019-2025
14 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $232 · 2023: $129 · 2024: $316 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $296.22 | 2023-2025 | Enhertu, Injectafer, Vanflyta |
| E.R. Squibb & Sons, L.L.C. | $157.62 | 2021-2022 | |
| Abbvie INC. | $135.36 | 2024-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $125.24 | 2022-2023 | Imbruvica |
| Celgene Corporation | $124.99 | 2021 | |
| Astellas Pharma US INC | $94.16 | 2021-2025 | Padcev, Vyloy |
| Janssen Biotech, INC. | $36.21 | 2021-2023 | Rybrevant |
| Seagen INC. | $26.99 | 2021 | |
| Genentech USA, INC. | $26.33 | 2023 | Tecentriq, Venclexta, Perjeta |
| Bayer Healthcare Pharmaceuticals INC. | $22.42 | 2025 | |
| Servier Pharmaceuticals LLC | $19.67 | 2025 | |
| Pfizer INC. | $19.60 | 2025 | |
| Immunocore Limited | $17.25 | 2024 | Kimmtrak |
| Genzyme Corporation | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Cogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.